The effect of heparin as a reversing agent of multidrug resistance (MD
R) was tested on normal mononuclear cells from 24 healthy volunteers a
nd leukaemic cells from 12 acute myeloid leukaemia, five chronic myelo
id leukaemia, five acute lymphoid leukaemia and three chronic lymphoid
leukaemia patients. Two cell lines were used as controls, the human e
rythroleukaemia K562 and its vincristine-resistant derivative K562-Luc
ena 1. Heparin was not cytotoxic by itself as determined using a MTT a
ssay and cell counts. MDR modulation was assessed by Rhodamine 123 ext
rusion using flow-cytometry. Modulation of the resistant cell line was
produced by the classical reversing agent verapamil and also by hepar
in, the same being observed in normal and leukaemic cells and being in
dependent of the type of leukaemia. Our work suggests that heparin may
be considered a potential MDR modulator.